vs

Side-by-side financial comparison of Organon & Co. (OGN) and WATSCO INC (WSO). Click either name above to swap in a different company.

WATSCO INC is the larger business by last-quarter revenue ($1.5B vs $1.5B, roughly 1.0× Organon & Co.). WATSCO INC runs the higher net margin — 6.1% vs -13.6%, a 19.7% gap on every dollar of revenue. On growth, WATSCO INC posted the faster year-over-year revenue change (0.1% vs -5.3%). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -15.3%).

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

Watsco, Inc. is a distributor of air conditioning, heating and refrigeration equipment, and related parts and supplies (HVAC/R) in the United States. Watsco was founded more than 60 years ago as a manufacturer of parts, components, and tools used in the HVAC/R industry. In 1989, the company shifted from manufacturing to distribution, by acquiring Gemaire Distributors Inc., a South Florida-based Rheem distributor.

OGN vs WSO — Head-to-Head

Bigger by revenue
WSO
WSO
1.0× larger
WSO
$1.5B
$1.5B
OGN
Growing faster (revenue YoY)
WSO
WSO
+5.5% gap
WSO
0.1%
-5.3%
OGN
Higher net margin
WSO
WSO
19.7% more per $
WSO
6.1%
-13.6%
OGN
Faster 2-yr revenue CAGR
OGN
OGN
Annualised
OGN
-3.6%
-15.3%
WSO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OGN
OGN
WSO
WSO
Revenue
$1.5B
$1.5B
Net Profit
$-205.0M
$92.9M
Gross Margin
49.2%
27.9%
Operating Margin
-9.8%
7.2%
Net Margin
-13.6%
6.1%
Revenue YoY
-5.3%
0.1%
Net Profit YoY
-288.1%
-1.7%
EPS (diluted)
$-0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OGN
OGN
WSO
WSO
Q1 26
$1.5B
Q4 25
$1.5B
$1.6B
Q3 25
$1.6B
$2.1B
Q2 25
$1.6B
$2.1B
Q1 25
$1.5B
$1.5B
Q4 24
$1.6B
$1.8B
Q3 24
$1.6B
$2.2B
Q2 24
$1.6B
$2.1B
Net Profit
OGN
OGN
WSO
WSO
Q1 26
$92.9M
Q4 25
$-205.0M
$71.7M
Q3 25
$160.0M
$161.6M
Q2 25
$145.0M
$183.6M
Q1 25
$87.0M
$80.1M
Q4 24
$109.0M
$96.8M
Q3 24
$359.0M
$171.0M
Q2 24
$195.0M
$181.4M
Gross Margin
OGN
OGN
WSO
WSO
Q1 26
27.9%
Q4 25
49.2%
27.1%
Q3 25
53.5%
27.5%
Q2 25
54.8%
29.3%
Q1 25
55.6%
28.1%
Q4 24
56.3%
26.7%
Q3 24
58.3%
26.2%
Q2 24
58.4%
27.1%
Operating Margin
OGN
OGN
WSO
WSO
Q1 26
7.2%
Q4 25
-9.8%
6.4%
Q3 25
15.2%
11.4%
Q2 25
14.4%
13.2%
Q1 25
6.7%
7.3%
Q4 24
8.1%
7.8%
Q3 24
13.1%
11.6%
Q2 24
14.6%
12.6%
Net Margin
OGN
OGN
WSO
WSO
Q1 26
6.1%
Q4 25
-13.6%
4.5%
Q3 25
10.0%
7.8%
Q2 25
9.1%
8.9%
Q1 25
5.8%
5.2%
Q4 24
6.8%
5.5%
Q3 24
22.7%
7.9%
Q2 24
12.1%
8.5%
EPS (diluted)
OGN
OGN
WSO
WSO
Q1 26
Q4 25
$-0.78
$1.82
Q3 25
$0.61
$3.98
Q2 25
$0.56
$4.52
Q1 25
$0.33
$1.93
Q4 24
$0.42
$2.42
Q3 24
$1.38
$4.22
Q2 24
$0.75
$4.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OGN
OGN
WSO
WSO
Cash + ST InvestmentsLiquidity on hand
$574.0M
$392.7M
Total DebtLower is stronger
$8.6B
Stockholders' EquityBook value
$752.0M
$3.2B
Total Assets
$12.9B
$4.6B
Debt / EquityLower = less leverage
11.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OGN
OGN
WSO
WSO
Q1 26
$392.7M
Q4 25
$574.0M
$733.3M
Q3 25
$672.0M
$524.3M
Q2 25
$599.0M
$293.0M
Q1 25
$547.0M
$431.8M
Q4 24
$675.0M
$781.9M
Q3 24
$763.0M
$550.0M
Q2 24
$704.0M
$424.9M
Total Debt
OGN
OGN
WSO
WSO
Q1 26
Q4 25
$8.6B
$361.6M
Q3 25
$8.8B
$340.8M
Q2 25
$8.9B
$338.7M
Q1 25
$9.0B
$346.4M
Q4 24
$8.9B
$337.2M
Q3 24
$8.7B
$321.0M
Q2 24
$8.7B
$307.1M
Stockholders' Equity
OGN
OGN
WSO
WSO
Q1 26
$3.2B
Q4 25
$752.0M
$2.8B
Q3 25
$906.0M
$2.8B
Q2 25
$733.0M
$2.8B
Q1 25
$542.0M
$2.7B
Q4 24
$472.0M
$2.7B
Q3 24
$493.0M
$2.7B
Q2 24
$144.0M
$2.6B
Total Assets
OGN
OGN
WSO
WSO
Q1 26
$4.6B
Q4 25
$12.9B
$4.4B
Q3 25
$13.6B
$4.6B
Q2 25
$13.5B
$4.7B
Q1 25
$13.2B
$4.5B
Q4 24
$13.1B
$4.5B
Q3 24
$12.8B
$4.5B
Q2 24
$12.2B
$4.4B
Debt / Equity
OGN
OGN
WSO
WSO
Q1 26
Q4 25
11.49×
0.13×
Q3 25
9.74×
0.12×
Q2 25
12.14×
0.12×
Q1 25
16.52×
0.13×
Q4 24
18.81×
0.13×
Q3 24
17.75×
0.12×
Q2 24
60.11×
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OGN
OGN
WSO
WSO
Operating Cash FlowLast quarter
$141.0M
Free Cash FlowOCF − Capex
$96.0M
FCF MarginFCF / Revenue
6.4%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$538.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OGN
OGN
WSO
WSO
Q1 26
Q4 25
$141.0M
$399.8M
Q3 25
$264.0M
$354.9M
Q2 25
$220.0M
$-7.4M
Q1 25
$75.0M
$-177.6M
Q4 24
$390.0M
$378.9M
Q3 24
$141.0M
$232.8M
Q2 24
$332.0M
$57.7M
Free Cash Flow
OGN
OGN
WSO
WSO
Q1 26
Q4 25
$96.0M
$388.5M
Q3 25
$218.0M
$346.1M
Q2 25
$181.0M
$-14.3M
Q1 25
$43.0M
$-185.2M
Q4 24
$335.0M
$370.9M
Q3 24
$99.0M
$223.0M
Q2 24
$300.0M
$51.3M
FCF Margin
OGN
OGN
WSO
WSO
Q1 26
Q4 25
6.4%
24.6%
Q3 25
13.6%
16.7%
Q2 25
11.4%
-0.7%
Q1 25
2.8%
-12.1%
Q4 24
21.0%
21.1%
Q3 24
6.3%
10.3%
Q2 24
18.7%
2.4%
Capex Intensity
OGN
OGN
WSO
WSO
Q1 26
Q4 25
3.0%
0.7%
Q3 25
2.9%
0.4%
Q2 25
2.4%
0.3%
Q1 25
2.1%
0.5%
Q4 24
3.5%
0.5%
Q3 24
2.7%
0.5%
Q2 24
2.0%
0.3%
Cash Conversion
OGN
OGN
WSO
WSO
Q1 26
Q4 25
5.57×
Q3 25
1.65×
2.20×
Q2 25
1.52×
-0.04×
Q1 25
0.86×
-2.22×
Q4 24
3.58×
3.91×
Q3 24
0.39×
1.36×
Q2 24
1.70×
0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons